http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7396922-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067f2f04a79f8fa507ccee5878585c9b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9a9de0d76f3fe83b5a7ccfc3c435ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44785a11f96478d1ff6c17e9af721499 |
| publicationDate | 2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-7396922-B2 |
| titleOfInvention | Regulation of hypoxia-inducible gene expression with antisense Inhibitory PAS domain protein |
| abstract | A pharmaceutical composition comprises the sequence of SEQ ID NO:s 3-5 or pharmaceutically equivalent sequences. Methods employing the pharmaceutical compositions include treatments to increase angiogenesis, to stimulate HIF-1α function, to treat hypoxia-related conditions, and to maintain normal cell functions under hypoxia. |
| priorityDate | 2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.